The patients with SSc with mRSS progression displayed a numerical elevation in baseline levels (p=0.102) of anti-PRMT5 antibody compared with the patients with SSc without skin fibrosis progression (figure 4C). The gene discussed is PRMT5; the disease is systemic sclerosis.